GRM1 and bone neoplasm: A recent study showed that GRM1 immunohistochemistry may be a useful ancillary technique to confirm the diagnosis of CMF and to differentiate it from morphological mimics, since it is not expressed in other bone tumours, which may be considered in the differential diagnosis with CMF [3].